About Alterman, Modi & Wolter
Clinical Trials at Alterman, Modi & Wolter
During the past decade, Alterman, Modi & Wolter conducted 9 clinical trials. In the 10-year time frame, 9 clinical trials started and 3 clinical trials were completed, i.e. on
average, 33.3% percent of trials that started reached the finish line to date. In the past 5 years, 5 clinical trials started and 3 clinical trials were completed. i.e. 60%
of trials that started reached the finish line.
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Alterman, Modi & Wolter" #1 sponsor was "Surface Ophthalmics, Inc." with 3 trials, followed by "Allergan" with 2 trials
sponsored, "AcuFocus, Inc." with 1 trials sponsored, "Formosa Pharmaceuticals, Inc." with 1 trials sponsored and "Reata Pharmaceuticals, Inc."
with 1 trials sponsored. Other sponsors include -4 different institutions and
companies that sponsored additional 6 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Alterman, Modi & Wolter"
#1 collaborator was "AbbVie" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were
collaborators in the rest 1 trials.
Clinical Trials Conditions at Alterman, Modi & Wolter
According to Clinical.Site data, the most researched conditions in "Alterman, Modi & Wolter" are
"Dry Eye Disease" (2 trials), "Presbyopia" (2 trials), "Cataract" (1 trials), "Cataract Surgery" (1 trials) and "Corneal Endothelial Cell Loss" (1 trials). Many other conditions were trialed in "Alterman, Modi & Wolter" in a lesser frequency.
Clinical Trials Intervention Types at Alterman, Modi & Wolter
Most popular intervention types in "Alterman, Modi & Wolter" are "Drug" (8 trials), "Other" (3 trials) and "Device" (1 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (3 trials), "0.02% Betamethasone Sodium Phosphate" (1 trials), "0.04% Betamethasone Sodium Phosphate" (1 trials), "0.5% Omaveloxolone Ophthalmic Suspension" (1 trials) and "1% Omaveloxolone Ophthalmic Suspension" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Alterman, Modi & Wolter
The vast majority of trials in "Alterman, Modi & Wolter" are
9 trials for "All" genders.
Clinical Trials Status at Alterman, Modi & Wolter
Currently, there are NaN active trials in "Alterman, Modi & Wolter".
undefined are not yet recruiting,
undefined are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 9 completed trials in Alterman, Modi & Wolter,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Alterman, Modi & Wolter, 1 "Phase 1"
clinical trials were conducted, 5 "Phase 2" clinical
trials and 3 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 1 trials that are defined as “Not Applicable".